Alzamend Neuro Inc (ALZN) Stock Price

1.83 ▼ -0.06 (-3.17%)
Open: 1.85 Vol: 121.85K Day's range: 1.71 - 1.8792 Mar 20, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALZN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.78▲ 1.78▲ 1.78▲ 1.92▼ 1.97▼
MA10 1.83▼ 1.83▼ 1.82▲ 2.02▼ 2.01▼
MA20 1.83▼ 1.84▼ 1.84▼ 2.01▼ 2.09▼
MA50 1.89▼ 1.98▼ 2.02▼ 2.06▼ 2.84▼
MA100 2.04▼ 2.03▼ 2.01▼ 2.14▼ 12.69▼
MA200 2.06▼ 1.97▼ 1.99▼ 2.40▼ 41.42▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ 0.001▲ -0.001▼ -0.019▼ 0.116▲
RSI 47.065▼ 44.646▼ 43.619▼ 41.442▼ 37.287▼
STOCH 15.215▼ 15.580▼ 15.580▼ 26.411     34.555    
WILL %R -50.000     -50.000     -50.000     -81.439▼ -73.822    
CCI -18.659     -3.106     -16.411     -129.130▼ -47.039    
Latest Filters Detected On ALZN
▼ GAP $ALZN Open Gap Down %2 Set Alert
Alzamend Neuro Inc News
Alzamend Neuro Initiates Phase II Clinical Trial of AL001 "Lithium in Brain" Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital
Monday, March 16, 2026 06:12 AM
Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar ...
Alzamend Neuro Establishes ATM Equity Offering Agreement
Friday, March 13, 2026 01:56 AM
Detailed price information for Alzamend Neuro Inc (ALZN-Q) from The Globe and Mail including charting and trades.
Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital
Wednesday, November 19, 2025 05:00 AM
ATLANTA, Nov. 19, 2025 /PRNewswire/ -- Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel ...
ALZN historical stock data
date open high low close volume
20/03/26 1.85 1.8792 1.71 1.83 121,854
19/03/26 1.90 1.96 1.76 1.89 89,630
18/03/26 1.90 1.93 1.821 1.92 75,900
17/03/26 2.12 2.19 1.82 1.86 387,200
16/03/26 2.245 2.3565 2.10 2.10 802,858
13/03/26 2.06 2.116 2.02 2.04 57,900
12/03/26 2.15 2.17 2.0506 2.09 44,409
11/03/26 2.15 2.2219 2.022 2.18 57,132
10/03/26 2.09 2.2301 2.09 2.14 69,488
09/03/26 2.04 2.25 1.9908 2.10 103,676
Quote Details
52wk Low:1.58
52wk High:10.17
Vol:121.85K
Avg Vol(3m):1.7M
1Y Chng:-79.31%
1M Chng:-7.58%
Add to Watch List
More Information
Index US Composite
Market Cap. 7.19M